PL3737403T3 - Zmodyfikowane adenowirusy - Google Patents
Zmodyfikowane adenowirusyInfo
- Publication number
- PL3737403T3 PL3737403T3 PL19711157.8T PL19711157T PL3737403T3 PL 3737403 T3 PL3737403 T3 PL 3737403T3 PL 19711157 T PL19711157 T PL 19711157T PL 3737403 T3 PL3737403 T3 PL 3737403T3
- Authority
- PL
- Poland
- Prior art keywords
- modified adenoviruses
- adenoviruses
- modified
- Prior art date
Links
- 241000701161 unidentified adenovirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10345—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1802539.5A GB201802539D0 (en) | 2018-02-16 | 2018-02-16 | Modified adenoviruses |
| PCT/GB2019/050380 WO2019158914A1 (en) | 2018-02-16 | 2019-02-13 | Modified adenoviruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3737403T3 true PL3737403T3 (pl) | 2024-03-18 |
Family
ID=61783770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19711157.8T PL3737403T3 (pl) | 2018-02-16 | 2019-02-13 | Zmodyfikowane adenowirusy |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20210100855A1 (pl) |
| EP (1) | EP3737403B1 (pl) |
| JP (2) | JP2021513843A (pl) |
| KR (1) | KR102687425B1 (pl) |
| CN (2) | CN112020368B (pl) |
| AU (1) | AU2019220607B2 (pl) |
| CA (1) | CA3090859A1 (pl) |
| DK (1) | DK3737403T5 (pl) |
| ES (1) | ES2968387T3 (pl) |
| FI (1) | FI3737403T3 (pl) |
| GB (1) | GB201802539D0 (pl) |
| IL (1) | IL276535A (pl) |
| PL (1) | PL3737403T3 (pl) |
| PT (1) | PT3737403T (pl) |
| SG (1) | SG11202007470QA (pl) |
| WO (1) | WO2019158914A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| CA3013637A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| WO2017147269A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| CN110062630A (zh) | 2016-12-12 | 2019-07-26 | 萨克生物研究学院 | 肿瘤靶向合成腺病毒及其用途 |
| WO2022208056A1 (en) * | 2021-03-29 | 2022-10-06 | University College Cardiff Consultants Limited | Modified adenovirus |
| GB202214580D0 (en) | 2022-10-04 | 2022-11-16 | Univ College Cardiff Consultants Ltd | Adenoviral vector therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004099422A2 (en) * | 2003-03-28 | 2004-11-18 | The Scripps Research Institute | Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| GB0520068D0 (en) * | 2005-10-03 | 2005-11-09 | Cancer Res Technology | av peptide ligand |
| ES2367227T3 (es) * | 2007-03-14 | 2011-10-31 | Institut Catala D'oncologia | Adenovirus con mutaciones en el dominio de retención en el retículo endoplasmático de la proteína e3-19k y su utilización en el tratamiento del cáncer. |
| CN102014948A (zh) * | 2008-02-07 | 2011-04-13 | 安德鲁·贝克 | 腺病毒向性的调节 |
| RU2013118724A (ru) * | 2010-09-24 | 2014-10-27 | Онкос Терапьютикс Ой | Онколитические аденовирусные векторы и связанные с ними способы и применения |
| WO2016118433A1 (en) * | 2015-01-20 | 2016-07-28 | Shayakhmetov Dmitry M | Detargeted adenovirus variants and related methods |
-
2018
- 2018-02-16 GB GBGB1802539.5A patent/GB201802539D0/en not_active Ceased
-
2019
- 2019-02-13 SG SG11202007470QA patent/SG11202007470QA/en unknown
- 2019-02-13 FI FIEP19711157.8T patent/FI3737403T3/fi active
- 2019-02-13 US US16/970,003 patent/US20210100855A1/en active Pending
- 2019-02-13 WO PCT/GB2019/050380 patent/WO2019158914A1/en active Application Filing
- 2019-02-13 PT PT197111578T patent/PT3737403T/pt unknown
- 2019-02-13 CN CN201980026226.XA patent/CN112020368B/zh active Active
- 2019-02-13 DK DK19711157.8T patent/DK3737403T5/da active
- 2019-02-13 PL PL19711157.8T patent/PL3737403T3/pl unknown
- 2019-02-13 ES ES19711157T patent/ES2968387T3/es active Active
- 2019-02-13 KR KR1020207026679A patent/KR102687425B1/ko active IP Right Grant
- 2019-02-13 CA CA3090859A patent/CA3090859A1/en active Pending
- 2019-02-13 EP EP19711157.8A patent/EP3737403B1/en active Active
- 2019-02-13 CN CN202410794965.6A patent/CN118834841A/zh active Pending
- 2019-02-13 JP JP2020543282A patent/JP2021513843A/ja active Pending
- 2019-02-13 AU AU2019220607A patent/AU2019220607B2/en active Active
-
2020
- 2020-08-05 IL IL276535A patent/IL276535A/en unknown
-
2023
- 2023-11-10 JP JP2023191972A patent/JP2024020345A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR102687425B1 (ko) | 2024-07-22 |
| JP2021513843A (ja) | 2021-06-03 |
| PT3737403T (pt) | 2024-01-24 |
| EP3737403A1 (en) | 2020-11-18 |
| CA3090859A1 (en) | 2019-08-22 |
| SG11202007470QA (en) | 2020-09-29 |
| DK3737403T5 (da) | 2024-08-26 |
| ES2968387T3 (es) | 2024-05-09 |
| EP3737403B1 (en) | 2024-01-03 |
| CN118834841A (zh) | 2024-10-25 |
| WO2019158914A1 (en) | 2019-08-22 |
| FI3737403T3 (fi) | 2024-01-17 |
| KR20200122346A (ko) | 2020-10-27 |
| GB201802539D0 (en) | 2018-04-04 |
| DK3737403T3 (da) | 2024-01-22 |
| IL276535A (en) | 2020-09-30 |
| AU2019220607B2 (en) | 2024-02-15 |
| AU2019220607A1 (en) | 2020-09-17 |
| CN112020368A (zh) | 2020-12-01 |
| CN112020368B (zh) | 2024-07-12 |
| JP2024020345A (ja) | 2024-02-14 |
| US20210100855A1 (en) | 2021-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3793565T3 (en) | Mcl-1-inhibitorer | |
| DK3467457T3 (en) | Vibrationssensor | |
| DK3759096T3 (en) | Cd73-inhibitorer | |
| SG11202113187WA (en) | Modified adenoviruses | |
| CA185383S (en) | Casque | |
| CA185382S (en) | Casque | |
| CA185384S (en) | Casque | |
| CA185385S (en) | Casque | |
| IL276535A (en) | adapted adenoviruses | |
| DK3773537T3 (en) | Stat3-hæmmere | |
| DK3554057T3 (en) | Audioheadsetsystem | |
| DK3872428T3 (en) | Indvendigt luftstyringssystem | |
| DK3768830T3 (en) | Cancerterapi | |
| ZA202005848B (en) | Modified oncolytic adenoviruses | |
| DK3613739T3 (en) | Integrin-antagonister | |
| DK3753395T3 (en) | Indvendigt luftstyringssystem | |
| CA184991S (en) | Uroflowmeter | |
| DK3633783T3 (en) | Universal-powerbank | |
| DK3801538T3 (en) | Tlr7-agonister | |
| CA184994S (en) | Uroflowmeter | |
| EP3841303C0 (de) | Mikrogebläse | |
| DK3768906T3 (en) | Træmodul | |
| DK3674425T3 (en) | Stålwire | |
| DK3650069T3 (en) | Trakeostomiventil | |
| DK3578923T3 (en) | Navigationssystem |